Comparison of real world and core laboratory lupus anticoagulant results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) clinical database and repository
Efthymiou, Maria; Mackie, Ian J.; Lane, Philip J.; Andrade, Danieli; Willis, Rohan; Erkan, Doruk; Sciascia, Savino; Krillis, Steven; Bison, Elisa; Borges Galhardo Vendramini, Margarete; Romay‐penabad, Zurina; Qi, Miao; Tektonidou, Maria; Ugarte, Amaia; Chighizola, Cecilia; Belmont, H. Michael; Aguirre, Maria Angeles; Ji, Lanlan; Branch, D. Ware; Jesus, Guilherme; Fortin, Paul R.; Andreoli, Laura; Petri, Michelle; Cervera, Ricard; Rodriguez, Esther; Knight, Jason S.; Atsumi, Tatsuya; Vega, Joann; Sevim, Ecem; Bertolaccini, Maria Laura; Pengo, Vittorio; Cohen, Hannah
2019-12
Citation
Efthymiou, Maria; Mackie, Ian J.; Lane, Philip J.; Andrade, Danieli; Willis, Rohan; Erkan, Doruk; Sciascia, Savino; Krillis, Steven; Bison, Elisa; Borges Galhardo Vendramini, Margarete; Romay‐penabad, Zurina ; Qi, Miao; Tektonidou, Maria; Ugarte, Amaia; Chighizola, Cecilia; Belmont, H. Michael; Aguirre, Maria Angeles; Ji, Lanlan; Branch, D. Ware; Jesus, Guilherme; Fortin, Paul R.; Andreoli, Laura; Petri, Michelle; Cervera, Ricard; Rodriguez, Esther; Knight, Jason S.; Atsumi, Tatsuya; Vega, Joann; Sevim, Ecem; Bertolaccini, Maria Laura; Pengo, Vittorio; Cohen, Hannah (2019). "Comparison of real world and core laboratory lupus anticoagulant results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) clinical database and repository." Journal of Thrombosis and Haemostasis 17(12): 2069-2080.
Abstract
BackgroundVariability remains a challenge in lupus anticoagulant (LA) testing.ObjectiveTo validate LA test performance between Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Core laboratories and examine agreement in LA status between Core and local/hospital laboratories contributing patients to this prospective registry.MethodsFive Core laboratories used the same reagents, analyzer type, protocols, and characterized samples for LA validation. Nonâ anticoagulated registry samples were retested at the corresponding regional Core laboratories and anticoagulated samples at a single Core laboratory. Categorical agreement and discrepancies in LA status between Core and local/hospital laboratories were analyzed.ResultsClotting times for the reference/characterized plasmas used for normalized ratios were similar between Core laboratories (CV <4%); precision and agreement for LA positive/negative plasma were similar (all CV â ¤5%) in the four laboratories that completed both parts of the validation exercise; 418 registry samples underwent LA testing. Agreement for LA positive/negative status between Core and local/hospital laboratories was observed in 87% (115/132) nonâ anticoagulated and 77% (183/237) anticoagulated samples. However, 28.7% (120/418) of samples showed discordance between the Core and local/hospital laboratories or equivocal LA results. Some of the results of the local/hospital laboratories might have been unreliable in 24.7% (41/166) and 23% (58/252) of the total nonâ anticoagulated and anticoagulated samples, respectively. Equivocal results by the Core laboratory might have also contributed to discordance.ConclusionsLaboratories can achieve good agreement in LA performance by use of the same reagents, analyzer type, and protocols. The standardized Core laboratory results underpin accurate interpretation of APS ACTION clinical data.Publisher
Wiley Periodicals, Inc. Clinical and Laboratory Standards Institute
ISSN
1538-7933 1538-7836
Other DOIs
Types
Article
Metadata
Show full item recordCollections
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.